Intel's Q1 results were relatively weak. The rising macro risks might affect its sales and costs in the following quarters. Intel remains a SELL for us right now.
Intel reported better-than-expected Q1 earnings despite no revenue growth, with adjusted EPS of $0.13 and revenues of $12.7B, beating estimates. Intel's restructuring is ongoing: the chipmaker sold a majority stake in Altera and focuses on core processor manufacturing for consumer and Data Center markets. Generative AI spending trends heavily work in favor of the chip-making industry.
The three major microchip stocks that I follow all look as if they are trying to recover a bit on Thursday, and in premarket trading are showing that buyers have returned yet again.
Intel (INTC 2.16%) launched its Arrow Lake family of desktop central processing units (CPUs), officially the Core Ultra 200 series, in late 2024. The company outsourced most of the manufacturing to TSMC, moved to a chiplet-based architecture, and managed to improve energy efficiency substantially, compared to its previous-generation chips.
Trading near its 52-week low around $20, Intel NASDAQ: INTC presents a seemingly inexpensive investment in the semiconductor sector as we near the middle of 2025. This low valuation, however, clashes with Intel's analyst community's cautious consensus rating and a weak financial outlook following a better-than-expected first quarter.
Intel shareholders on Tuesday approved a company measure aimed at topping up share reserves to attract and retain new employees and compensation for new CEO Lip-Bu Tan.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.